Carcinoid Syndrome

Common Name(s)

Carcinoid Syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Carcinoid Syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Carcinoid Syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Carcinoid Syndrome" returned 103 free, full-text research articles on human participants. First 3 results:

Primary neuroendocrine mediastinal tumor presenting with carcinoid syndrome and left supraclavicular lymphadenopathy: clinico-radiological and pathological features.
 

Author(s): Amit Nandan D Dwivedi, Kanika Goel, Suchi Tripathi, Sunny Garg, Madhukar Rai

Journal: J Cancer Res Ther. ;9(2):278-80.

 

Primary mediastinal neuro-endocrine tumor is very rare. The primary modality to evaluate the lesion is computed tomography, to know disease extent, involvement of various structures, vascular invasion and metastasis. Histo-pathological and immuno-histochemical confirmation is mandatory. ...

Last Updated: 17 Jun 2013

Go To URL
Circulating serotonin and bone density, structure, and turnover in carcinoid syndrome.
 

Author(s): Jennifer S Walsh, John D Newell-Price, Miguel DeBono, Joanne Adaway, Brian Keevil, Richard Eastell

Journal: J. Clin. Endocrinol. Metab.. 2013 Jul;98(7):2902-7.

 

Gut-derived serotonin has been proposed as a regulator of bone formation, and inhibition of gut serotonin synthesis increases bone formation in rodents. Carcinoid neuroendocrine tumors can produce very high levels of circulating serotonin and so offer a model of serotonin excess in humans.

Last Updated: 9 Jul 2013

Go To URL
Collision adenoma-carcinoid tumour of the colon complicated by carcinoid syndrome.
 

Author(s): Chee-Kin Hui

Journal: Singapore Med J. 2012 Sep;53(9):e195-7.

 

Tumours consisting of a glandular component, either an adenoma or adenocarcinoma, and a carcinoid component are uncommon. These tumours can be differentiated into collision, composite or amphicrine tumours. Most cases reported in the literature were mixed adenocarcinoma-carcinoid ...

Last Updated: 1 Oct 2012

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Carcinoid Syndrome" returned 9 free, full-text review articles on human participants. First 3 results:

In patients with carcinoid syndrome undergoing valve replacement: will a biological valve have acceptable durability?
 

Author(s): Nigel Mabvuure, Alex Cumberworth, Sandip Hindocha

Journal: Interact Cardiovasc Thorac Surg. 2012 Sep;15(3):467-71.

 

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'In patients with carcinoid syndrome undergoing valve replacement, will a biological valve have acceptable durability?' Altogether, more than 130 papers were found using ...

Last Updated: 21 Aug 2012

Go To URL
The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome.
 

Author(s): Anne Klibanski, Shlomo Melmed, David R Clemmons, Annamaria Colao, Regina S Cunningham, Mark E Molitch, Aaron I Vinik, Daphne T Adelman, Karen J P Liebert

Journal: Pituitary. 2010 Sep;13(3):266-86.

 

The Endocrine Tumor Summit convened in December 2008 to address 6 statements prepared by panel members that reflect important questions in the treatment of acromegaly and carcinoid syndrome. Data pertinent to each of the statements were identified through review of pertinent literature ...

Last Updated: 2 Aug 2010

Go To URL
Carcinoid syndrome: diagnosis and medical management.
 

Author(s): Aart J van der Lely, Wouter W de Herder

Journal: Arq Bras Endocrinol Metabol. 2005 Oct;49(5):850-60.

 

Gastro-intestinal carcinoids are slow growing tumors arising from enterochromaffin or Kulchitsky cells. Their clinical presentation depends on what combination of bioactive substances is secreted. Midgut carcinoid can present with the carcinoid syndrome in the presence of liver metastases. ...

Last Updated: 30 Jan 2006

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Telotristat Etiprate for Carcinoid Syndrome Therapy
 

Status: Recruiting

Condition Summary: Carcinoid Syndrome

 

Last Updated: 29 Jul 2014

Go to URL

Last Updated: 3 Jul 2014

Go to URL
Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms
 

Status: Recruiting

Condition Summary: Carcinoid Syndrome

 

Last Updated: 11 Aug 2014

Go to URL